The effect of Bifidobacterium on intestinal bacterial flora and putrefactive products in hemodialysis

Kouji Minami; Shinji Tanaka; Kazuyuki Takahashi; Masataka Tsujino; Hiroshi Tanimura; Kiwao Ishimoto; Takuya Tsunoda; Yoshiya Umemoto; Noriaki Tanaka; Kazuto Masaki; Yoshifumi Mibu; Yoshifumi Bandou; Ikuyo Minamino

doi:10.4009/jsdt.32.349

Kouji Minami, Shinji Tanaka, Kazuyuki Takahashi, Masataka Tsujino, Hiroshi Tanimura, Kiwao Ishimoto, Takuya Tsunoda, Yoshiya Umemoto, Noriaki Tanaka, Kazuto Masaki, Yoshifumi Mibu, Yoshifumi Bandou, Ikuyo Minamino

Author information

JOURNAL FREE ACCESS

1999 Volume 32 Issue 5 Pages 349-356

DOI https://doi.org/10.4009/jsdt.32.349

Details

Abstract

Analysis of intestinal microflora revealed an imbalance in its composition characterized by overgrowth of aerobic bacteria in feces of hemodialysis patients. Balance was restored by administration of a Bifidobacterium capsule, which increased the level of Bifidobacterium. A significant decrease in the amount of putrefactive products such as fecal ammonia, phenol, and scatole was observed. No adverse effects were observed. These results indicate the usefulness of Bifidobacterium for hemodialysis patients.

Corresponding author

Register with J-STAGE for free!